CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 5, 2022 · earnings

INMB earnings: a negative outcome, -8.5%

On May 5, 2022, INmune Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.5% in the window around the event.

The move

$7.90
1d before
$7.23
Event day
$7.51
1d after
$6.89
5d after

Pre-catalyst setup

-3.7%
30-day run-up
9808%
30-day volatility
0.9×
volume spike